Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy

2009/03/19 by S Mustjoki, Satu Mustjoki, Marja Ekblom +37 · 3 citations
Medicine · #Chronic Myeloid Leukemia Treatments #Chronic Lymphocytic Leukemia Research #Lymphoma Diagnosis and Treatment

paper · doi:10.1038/leu.2009.46

Cited by

• Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation
• Chronic inflammation deters natural killer cell fitness and cytotoxicity in myeloid leukemia
• Dasatinib Exposure and Risk of CMV Reactivation in Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia